We found that NPC cell lines with low expression of NSUN2 had higher sensitivity to AZD6482 and PF.02341066, which may provide a new choice for selecting chemotherapy drugs for NPC patients. The gene discussed is NSUN2; the disease is nasopharyngeal carcinoma.